Selected announcements from A-shares | Yushu Technology (688836.SH): Initial public offering price of 150.8 yuan per share.
Yushu Technology announced on August 6 that the initial public offering price is 150.8 yuan per share.
Today's Focus
1. Tongyu Communication Inc. Clarifies: Jiaxian Communication Does Not Have a R&D Cooperation Relationship with NVIDIA
Tongyu Communication Inc. (002792) announced on August 6 that it previously disclosed plans to acquire approximately 25% equity in Shenzhen Jiaxian Communication Technology Co., Ltd. ("Jiaxian Communication") for 300 million yuan. Recently, online media circulated an article stating that "Jiaxian Communication is collaborating with NVIDIA to develop 6G AI-RAN base stations, and Tongyu Communication intends to acquire a 25% stake, targeting a 200 billion yuan market." After verification, Jiaxian Communication does not have a research and development cooperation relationship with NVIDIA. Jiaxian Communication's technology development for 6G AI-RAN base stations is based on NVIDIA's CUDA Aerial open-source ecological platform, which is publicly available and does not involve exclusive licenses or exclusive cooperation arrangements. There is significant uncertainty regarding whether the 6G AI-RAN base stations developed subsequently by Jiaxian Communication will meet market demands in terms of functionality, performance, and stability, and whether they will successfully gain recognition from downstream customers.
2. Shanxi Coking Coal Energy Group: Production Halted at Xiqu Mine Due to Safety Incident
Shanxi Coking Coal Energy Group (000983) announced on August 6 that a safety production accident occurred at its Xiqu mine on August 5, resulting in one fatality. The Xiqu mine has been shut down, and relevant government departments are conducting an investigation into the incident. The Xiqu mine is a subsidiary of the company, with an annual approved production capacity of 2.7 million tons, accounting for 5.67% of the company's total approved production capacity.
3. Yushu Technology: Initial Public Offering Price Set at 150.8 Yuan per Share
Yushu Technology (688836) announced on August 6 that the initial public offering price is set at 150.8 yuan per share.
4. Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.: Plans to Acquire Controlling Stake in Innovative Pharmaceutical Company Bajiayi Through Wholly-Owned Subsidiary
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766) announced on August 6 that its wholly-owned subsidiary, Guilin Jinma Innovative Investment Co., Ltd. ("Guilin Jinma"), has signed a "Merger Intent Agreement" with Bajiayi Pharmaceutical Co., Ltd. ("Bajiayi") to acquire a controlling stake in Bajiayi through Guilin Jinma. Bajiayi was established in 2011 and is an innovative pharmaceutical company focused on original new drug research and development, having obtained 23 drug research and development patents and possessing clinical approvals for two class 1 chemical new drug varieties and one class 1 traditional Chinese medicine new drug variety.
5. Xingfa Group: Plans to Raise No More Than 3 Billion Yuan Through Private Placement with Participation from Controlling Shareholder
Xingfa Group (600141) announced on August 6 that the company plans to issue shares to no more than 35 specific investors, including its controlling shareholder Yichang Xingfa, for a total fundraising of up to 3 billion yuan, intended for the 2.8 million tons per year mining project at Qiaogou Phosphate Mine, the 5 million tons per year beneficiation project (Phase I) at the same mine, and to repay bank loans. Yichang Xingfa intends to subscribe for shares in this private placement for an amount not less than 100 million yuan (inclusive) and not more than 200 million yuan (inclusive).
6. China Rare Earth Nonferrous Metals: Plans to Transfer 37% Equity of Dongdianhua Company at No Less Than 142 Million Yuan
China Rare Earth Nonferrous Metals (600259) announced on August 6 that to optimize its asset structure and resource allocation, and to focus on core business, the company plans to publicly list and transfer its 37% equity in Guangdong Dongdianhua Guangsheng Rare Earth High-tech Materials Co., Ltd. ("Dongdianhua Company") through the Guangdong United Property Rights Exchange at a listing price of no less than 142 million yuan. Upon completion of this equity transfer, the company will no longer hold any equity in Dongdianhua Company.
7. Zhongfu Shenying Carbon Fiber: Plans to Raise No More Than 3.893 Billion Yuan Through Private Placement for High-Performance Carbon Fiber and Related Projects
Zhongfu Shenying Carbon Fiber (688295) announced on August 6 that it intends to issue shares to specific entities to raise no more than 3.893 billion yuan, which will be used for the construction project of 30,000 tons of high-performance carbon fiber per year, the research and development platform for ultra-high-modulus carbon fiber, and to supplement working capital.
8. Zhuhai Bojay Electronics: Clarifies Information on "Optical Communication Indium Phosphide" and Related Businesses
Zhuhai Bojay Electronics (002975) announced on August 6 that it has seen trading fluctuations due to recent discussions in the market regarding its involvement in "optical communication indium phosphide," "semiconductors," "optical modules," "liquid cooling," "humanoid Siasun Robot & Automation," and "MLCC." The company clarifies that the optical communication indium phosphide business mentioned in rumors is operated by its investment, Dingtai Chip Source. Currently, the company holds 11.049% of Dingtai Chip Sources shares, which has reported three consecutive years of losses and has not yet achieved profitability, which does not significantly impact the company's operating performance.
9. Lily Group Co., Ltd.: Sales Revenue from Photoresist Pigments Will Only Account for 0.084% of Company Revenue in 2025
Lily Group Co., Ltd. (603823) published a stock trading risk warning on August 6, verifying that its related high-performance pigmented products are applied in the field of photoresist for LCD displays. The sales revenue from photoresist pigments is projected to account for only 0.084% of the company's total revenue in 2025, representing a small proportion. Investors are urged to view market trends rationally, be aware of investment risks, and make prudent decisions.
10. Shenzhen Transsion Holdings Co., Ltd.: H Share Issuance Matter Registered with the China Securities Regulatory Commission
Shenzhen Transsion Holdings Co., Ltd. (688036) announced on August 6 that its issuance of overseas listed shares (H shares) has been registered with the China Securities Regulatory Commission.
11. Shenyang Cuihua Gold and Silver Jewelry: Suspected False Records May Trigger Major Violation and Mandatory Delisting
Shenyang Cuihua Gold and Silver Jewelry announced that due to suspected violations of information disclosure laws, it was subject to investigation by the China Securities Regulatory Commission starting from February 9, 2026. As of August 6, 2026, preliminary findings revealed that some annual financial disclosures may involve false records, potentially reaching a situation of major violations leading to mandatory delisting. If the facts determined by the China Securities Regulatory Commissions administrative penalties involve relevant regulations, the company's shares will be subject to mandatory delisting for major violations. Additionally, the company received a letter of inquiry from the Shenzhen Stock Exchange on August 6, 2026.
Operating Performance
1. Shandong Homey Aquatic Development: Net Profit of 29.9788 Million Yuan in the First Half of the Year, a Year-on-Year Increase of 21.74%
Shandong Homey Aquatic Development (600467) announced on August 6 that it achieved operating revenue of 803 million yuan in the first half of 2026, a year-on-year increase of 12.99%; the net profit attributable to shareholders of the listed company was 29.9788 million yuan, representing a year-on-year increase of 21.74%; basic earnings per share were 0.0205 yuan.
2. Jafron Biomedical: Net Profit for the First Half of the Year Was 382 Million Yuan, a Year-on-Year Decrease of 1.99%
Jafron Biomedical (300529) disclosed its interim report on August 6, showing that it achieved total operating revenue of 1.032 billion yuan in the first half of 2026, a year-on-year decrease of 8.99%; the net profit attributable to shareholders of the listed company was 382 million yuan, a year-on-year decrease of 1.99%; basic earnings per share were 0.49 yuan. During the reporting period, the companys overall revenue decreased year-on-year due to fluctuations in industry demand and intensified market competition.
3. Shenzhen Roadrover Technology: Loss of 22.0208 Million Yuan in the First Half of the Year, Year-on-Year Loss Reduction
Shenzhen Roadrover Technology (002813) announced on August 6 that it achieved operating revenue of 153 million yuan in the first half of 2026, a year-on-year decrease of 16.38%; the net profit attributable to shareholders of the listed company was a loss of 22.0208 million yuan, compared to a loss of 46.5096 million yuan in the same period last year. During the reporting period, the automotive electronics business achieved a year-on-year revenue increase of 11.02%, and with the continued implementation of fixed projects, the revenue scale of the automotive electronics business steadily increased, leading to a reduction in net loss year-on-year.
4. Hunan Zhenghong Science and Technology Development: July Sales Revenue from Live Pigs Was 5.404 Million Yuan, a Year-on-Year Decrease of 79.23%
Hunan Zhenghong Science and Technology Development (000702) announced on August 6 that 11,100 live pigs were sold in July, representing a month-on-month increase of 8.79% and a year-on-year decrease of 31.83%; the sales revenue was 5.404 million yuan, a month-on-month decrease of 28.65% and a year-on-year decrease of 79.23%. The average selling price of commodity pigs (excluding piglets and breeding pigs) in July was 10.57 yuan per kilogram, a year-on-year decrease of 28.39%. From January to July 2026, the company cumulatively sold 64,300 live pigs, a year-on-year decrease of 18.94%; and cumulative sales revenue was 55.5361 million yuan, a year-on-year decrease of 49.27%. The significant year-on-year decline in live pig sales prices and revenue was primarily impacted by fluctuations in the live pig market.
5. Jiangsu Lihua Foods Group: July Sales Revenue from Broilers Was 1.274 Billion Yuan, Month-on-Month Increase of 5.2%
Jiangsu Lihua Foods Group (300761) announced on August 6 that 51.4131 million broilers were sold in July, with sales revenue of 1.274 billion yuan and a gross selling price of 11.11 yuan per kilogram, with month-on-month changes of 5.45%, 5.2%, and -0.18% respectively, and year-on-year changes of 4.60%, 23.21%, and 13.72% respectively. In July, 177,200 live pigs were sold, with sales revenue of 24.4 million yuan and an average selling price of 11.16 yuan per kilogram, with month-on-month changes of -11.88%, -5.06%, and 11.27%, and year-on-year changes of 21.79%, -6.15%, and -24.34% respectively.
6. Jinhui Mining Incorporation: Net Profit in the First Half of the Year Increased by 61.52% Year-on-Year, Proposing a Cash Dividend of 3.3 Yuan per 10 Shares
Jinhui Mining Incorporation (603132) announced on August 6 that it achieved operating revenue of 1.085 billion yuan in the first half of 2026, a year-on-year increase of 37%; the net profit attributable to shareholders of the listed company was 409 million yuan, a year-on-year increase of 61.52%; basic earnings per share were 0.42 yuan. The company plans to distribute a cash dividend of 3.3 yuan per 10 shares (tax included).
7. Biocytogen Pharmaceuticals: Expected Net Profit Increase of 391.87%412.71% Year-on-Year in the First Half of the Year
Biocytogen Pharmaceuticals (688796) announced on August 6 that it expects to achieve a net profit attributable to the parent company of 236 million246 million yuan in the first half of 2026, representing a year-on-year increase of 391.87%412.71%. As the biopharmaceutical industry enters a new stage of innovation-led development, the company fully leverages its competitive advantages and deeply engages in business development opportunities arising from the industry's improving prosperity. During the reporting period, the company's two major business lines achieved dual drives and leap-forward collaboration, driving sustained high-speed revenue growth.
8. Jiangsu Zongyi: Net Profit of 47.1374 Million Yuan in the First Half of the Year, a Year-on-Year Increase of 136.92%
Jiangsu Zongyi (600770) announced on August 6 that it achieved operating revenue of 331 million yuan in the first half of 2026, a year-on-year increase of 55.18%; the net profit attributable to shareholders of the listed company was 47.1374 million yuan, a year-on-year increase of 136.92%; basic earnings per share were 0.0363 yuan.
Signing Major Contracts
1. Jilin Oled Material Tech: Wholly-Owned Subsidiary Wins 47.2815 Million Yuan AMOLED Production Line Upgrade Project
2. Zhejiang Songyuan Automotive Safety Systems: Wholly-Owned Subsidiary Receives Project Fixed Point Worth Approximately 690 Million Yuan
3. Anhui Construction Engineering Group Corporation: New Contract Value of Engineering Construction Business in the First Half of the Year Amounted to 42.617 Billion Yuan
4. Ningbo Sanxing Medical Electric: Controlling Subsidiary Signs Overseas Business Contract Worth About 175 Million Yuan
Buybacks & Changes in Holdings
1. LANGHONG TECHNOLOGY: Actual Controller, Directors, and Executives Intend to Reduce Holdings by No More Than 1.994%
2. Shenzhen Farben Information Technology: Obtained Financial Institution Support for Share Repurchase Financing of No More than 60 Million Yuan
3. Hubei Jumpcan Pharmaceutical: Directors Huang Qurong and Financial Director Yan Hongquan Intend to Reduce Holdings by No More Than 181,000 Shares
4. Yangfan New Materials: Plans to Repurchase Shares Worth 30 Million to 60 Million Yuan
5. Puya Semiconductor (Shanghai) Co., Ltd.: Received Commitment Letter for Special Loans for Share Repurchase of No More Than 45 Million Yuan
This article is reprinted from Tencent Self-Selected Stocks, edited by Xu Wenqiang.
Related Articles

The AI competition continues to heat up as Microsoft Corporation (MSFT.US) activates its largest data center in India.

Guangdong Create Century Intelligent Equipment Group Corporation (300083.SZ) plans to implement a restricted stock incentive plan in 2026.

Merck & Co., Inc. (MRK.US) has submitted its oral drug for the treatment of AIDS for market approval in China.
The AI competition continues to heat up as Microsoft Corporation (MSFT.US) activates its largest data center in India.

Guangdong Create Century Intelligent Equipment Group Corporation (300083.SZ) plans to implement a restricted stock incentive plan in 2026.

Merck & Co., Inc. (MRK.US) has submitted its oral drug for the treatment of AIDS for market approval in China.

RECOMMEND





